Clinical Trial

A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection

Study Status:

Study closed

Contact Information:

(956) 362-2396

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

To evaluate the effect of EDP1815 on pulmonary function as measured by the change in Oxygen Saturation (SpO2) / Fraction of Inspired Oxygen (FiO2) [S/F ratio]

Information:

Principal Investigator	Carlos A. Paris, MD
Co-PI	Luis Cantu Jr.
Sponsor	Evelo Biosciences Inc.
Type of Trial	Interventional

Contact Us For More Info Or To Apply

5323 S. McColl Rd., Edinburg, TX 78539

[email protected]

(956) 362-2390

Clinical Trial

A Phase 2 double-blind placebo-controlled study investigating the safety and efficacy of EDP1815 in the treatment of patients hospitalized with SARS-CoV-2 Infection

Study Status:

Contact Information:

Study Purpose:

Information:

Useful Links

For Research Participants

About Us

News & Views